The future of drug discovery: AI, simulated organs, and no more mice

Rapid new drug discovery had never been more critical in a world with an aging population and increased instances of infectious diseases. While traditional lab methods have proven reliable, the recent covid-19 pandemic has shown the need for further innovation. The global drug discovery market size was valued at US$ 74.96 billion in 2021.[1] Despite such massive investments, the number of new drugs approved by the FDA remains low. Current drug discovery methods are slow, expensive, dominated by big pharma, and require cruel animal testing procedures.